Get started
Author

Georg C. Lodde

Observed names: G. Lodde, Georg Lodde, Lodde, Georg
ORCID: 0000-0002-6930-2694
Observed ORCID: 0000-0002-6930-2694
OpenAlex ID: A5113344749
Adjuvant treatment and outcome of stage III melanoma patients: Results of a multicenter real-world German Dermatologic Cooperative Oncology Group (DeCOG) study
2023 · Georg C. Lodde, Jessica Hassel, et al. · European Journal of Cancer · 21
Early versus late response to PD-1-based immunotherapy in metastatic melanoma
2024 · Georg C. Lodde, Fang Zhao, et al. · European Journal of Cancer · 10
PDF
BioKGrapher: Initial evaluation of automated knowledge graph construction from biomedical literature
2024 · Henning Schäfer, Ahmad Idrissi-Yaghir, et al. · Computational and Structural Biotechnology Journal · 9
Multicenter real-world data of adjuvant treatment and disease outcome of patients with melanoma with high-risk of recurrence.
2022 · Elisabeth Livingstone, Andrea Forschner, et al. · Journal of Clinical Oncology · 7
Guideline-Based Context-Sensitive Decision Modeling for Melanoma Patients
2022 · Catharina Lena Beckmann, Georg Lodde, et al. · Studies in health technology and informatics · 4
PDF
Use of Real-World FHIR Data Combined with Context-Sensitive Decision Modeling to Guide Sentinel Biopsy in Melanoma
2024 · Catharina Lena Beckmann, Georg Lodde, et al. · Journal of Clinical Medicine · 3
Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A): the doctors’ perspective
2024 · Katharina C. Kähler, Ralf Gutzmer, et al. · Journal of Cancer Research and Clinical Oncology · 3
Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation status
2025 · Jan-Malte Placke, Luisa Sophie Rajcsanyi, et al. · Frontiers in Immunology · 2
PDF
Efficacy of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy.
2021 · Prachi Bhave, Angela M. Hong, et al. · Journal of Clinical Oncology · 2
Enhancing Healthcare Interoperability Using Large Language Models: A Generative Proof-of-Concept Framework to Extract Medical Information from Unstructured Clinical Text (Preprint)
2026 · Bahadır Eryılmaz, Kamyar Arzideh, et al.
MAPLE: Medical Aspect-Based Summarization with Phrase-Level Evidence
2026 · Chu, Bohao, Damm, Hendrik, et al. · arXiv (Cornell University)
PDF
eTracer: Polarity-Aware Evidence Grounding
2026 · Bohao Chu, Qianli Wang, et al. · Conference on Empirical Methods in Natural Language Processing (EMNLP)
PDF
Socioeconomic situation in Long-Term Survivors of Stage IV Melanoma
2026 · M. Reitmajer, E. Livingstone, et al. · EJC Skin Cancer
Long-Term Survivors With Melanoma Brain Metastases: Clinical Burden and Psychosocial Distress
2026 · M. Reitmajer, E. Livingstone, et al. · EJC Skin Cancer
Stage I melanoma patients with late recurrence: Insights from a retrospective, single-centre study
2026 · L. Schraeer, E. Livingstone, et al. · EJC Skin Cancer
Works count: 15
Citation count: 61
H-index: 4
I10-index: 2
Year
Topic
Type